Vitiligo: evidence brief
Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 · https://research.opensourcemed.info/briefs/vitiligo.html
Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.
Medicines with registered trials
Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.
- Ruxolitinib cream 6 trials
- PF-06651600 5 trials
- Ritlecitinib 3 trials
- SHR0302Base gel 2 trials
- Topical tacrolimus 0.1% ointment 2 trials
- Upadacitinib 2 trials
Non-drug approaches tested
Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.
- Light and laser therapy (photobiomodulation) 20 trials · 10 completed · 5 with results
- Vitamin D 2 trials · 2 completed · 0 with results
- Psychotherapy, counselling and peer support 1 trials · 1 completed · 0 with results
- Herbal medicines and traditional formulas 1 trials · 1 completed · 0 with results
- Other behavioural interventions 1 trials · 1 completed · 0 with results
Natural products (RepurpOS Moderate tier)
Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.
- Ginkgo Biloba
- Kutki
- Phlebodium Aureum
Trials recruiting
Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.
- A Study of EB06 Versus Placebo in Adults With Moderate to Severe Non-segmental… NCT07889492
- A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in… NCT07431177
- A Trial to Test the Safety and Efficacy of TEV-53408 in Participants With Vitiligo NCT06625177
- Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in… NCT07437560
- PALLAS Laser for Skin Diseases NCT07250997
- Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer… NCT07904910